Metaiodobenzylguanidine: Evaluation of Its Potential as a Tracer for Monitoring Doxorubicin Cardiomyopathy

Shigetoshi Wakasugi; Alan J. Fischman; John W. Babich; H. Thomas Aretz; Ronald J. Callahan; Motoe Nakaki; Robert Wilkinson; H. William Strauss

Research ArticleLaboratory Studies

Metaiodobenzylguanidine: Evaluation of Its Potential as a Tracer for Monitoring Doxorubicin Cardiomyopathy

Shigetoshi Wakasugi, Alan J. Fischman, John W. Babich, H. Thomas Aretz, Ronald J. Callahan, Motoe Nakaki, Robert Wilkinson and H. William Strauss

Journal of Nuclear Medicine August 1993, 34 (8) 1282-1286;

Shigetoshi Wakasugi

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alan J. Fischman

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John W. Babich

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

H. Thomas Aretz

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ronald J. Callahan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Motoe Nakaki

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert Wilkinson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

H. William Strauss

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 34, Issue 8

August 1, 1993

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Metaiodobenzylguanidine: Evaluation of Its Potential as a Tracer for Monitoring Doxorubicin Cardiomyopathy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Metaiodobenzylguanidine: Evaluation of Its Potential as a Tracer for Monitoring Doxorubicin Cardiomyopathy

Shigetoshi Wakasugi, Alan J. Fischman, John W. Babich, H. Thomas Aretz, Ronald J. Callahan, Motoe Nakaki, Robert Wilkinson, H. William Strauss

Journal of Nuclear Medicine Aug 1993, 34 (8) 1282-1286;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Metaiodobenzylguanidine: Evaluation of Its Potential as a Tracer for Monitoring Doxorubicin Cardiomyopathy

Shigetoshi Wakasugi, Alan J. Fischman, John W. Babich, H. Thomas Aretz, Ronald J. Callahan, Motoe Nakaki, Robert Wilkinson, H. William Strauss

Journal of Nuclear Medicine Aug 1993, 34 (8) 1282-1286;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

Google Scholar

Cited By...

No citing articles found.

Google Scholar

Main menu

User menu

Search

Metaiodobenzylguanidine: Evaluation of Its Potential as a Tracer for Monitoring Doxorubicin Cardiomyopathy

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles